Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Regenerative Scalp Preparation With Stromal Vascular Fraction and Platelet-Rich Fibrin Prior to Hair Transplantation in Lichen Planus: A Case Report.

Bozorg Savoji P., Mirbahari SN., Rafiee S., Fakhim T., Nilforoushzadeh MA.

Prospective Study on Hair Loss, published in Clin Case Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Clin Case Rep (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42006542
PMCID
PMC13090173
DOI
10.1002/ccr3.72084

Abstract (original English)

Lichen planus (LP) is a chronic inflammatory scalp disorder that can lead to cicatricial alopecia, making it challenging for hair transplantation. This case report describes a 26-year-old female with LP who underwent scalp preparation using SVF and PRF before hair transplantation. SVF was administered 6 weeks prior, followed by PRF 4 weeks before the procedure to enhance scalp vascularization and reduce inflammation. After 1 year of follow-up, significant graft survival and improved scalp condition were observed without major complications. This report highlights the potential of SVF and PRF in optimizing hair transplantation outcomes for patients with LP.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research